Discover why so many are choosing KESIMPTA, and get insights from people who take it—sign up here to learn more.
ANDY M.
Dad, Account Executive
Chose KESIMPTA as 1st treatment: 2022
HEAR WHAT PEOPLE ARE SAYING
"Between work and being a dad, I'm always busy. But KESIMPTA fit my life, plus had significant results—reducing relapses and slowing disability progression. That impressed me.‡"
Individual results may vary.
‡Reduced annual rate of relapses by 51% and 58%, reduced disability progression by 34% at 3 months and 32% at 6 months in 2 studies vs teriflunomide.
KARINA L.
Photographer, Music Festival Fan
Chose KESIMPTA as 1st treatment: 2022
LEARN HOW TO TAKE KESIMPTA
”Since this was my 1st treatment, I was nervous about giving myself a shot. But once I tried the
auto-injector pen, I was like—yeah I got this!"
Prescribed KESIMPTA?
97% of all prescriptions filled have a $0 out of pocket cost when used with the Access Card§‖ from the Alongside™ KESIMPTA Patient Support Program.
All people shown on this webpage are living with relapsing multiple sclerosis, have taken KESIMPTA, and have been compensated for their time.
MS, multiple sclerosis; RMS, relapsing multiple sclerosis.
§Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at start.kesimpta.com.
‖2023 data on file.